299 related articles for article (PubMed ID: 28385631)
1. Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: A patient friendly approach to manage arthritis.
Amodwala S; Kumar P; Thakkar HP
Eur J Pharm Sci; 2017 Jun; 104():114-123. PubMed ID: 28385631
[TBL] [Abstract][Full Text] [Related]
2. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
[TBL] [Abstract][Full Text] [Related]
3. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
[TBL] [Abstract][Full Text] [Related]
5. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
[TBL] [Abstract][Full Text] [Related]
6. Vinpocetine loaded ultradeformable liposomes as fast dissolving microneedle patch: Tackling treatment challenges of dementia.
Srivastava PK; Thakkar HP
Eur J Pharm Biopharm; 2020 Nov; 156():176-190. PubMed ID: 32956837
[TBL] [Abstract][Full Text] [Related]
7. Development of a Novel Self-Dissolving Microneedle-Assisted Percutaneous Delivery System of Diacerein through Solid Dispersion Gel: Solubility Enhancement, Proof of Anti-inflammatory Activity and Safety.
Shabbir M; Barkat K; Ashraf MU; Nagra U
Curr Drug Deliv; 2023; 20(9):1351-1367. PubMed ID: 35770410
[TBL] [Abstract][Full Text] [Related]
8. QbD-driven development of dissolving microneedle patch loaded with ultradeformable liposomes encapsulated Noopept: Exploring a patient friendly, once-daily option to manage dementia.
Srivastava PK; Thakkar HP
Eur J Pharm Sci; 2021 Sep; 164():105909. PubMed ID: 34126240
[TBL] [Abstract][Full Text] [Related]
9. Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies.
Yener G; Üner M; Gönüllü Ü; Yildirim S; Kiliç P; Aslan SS; Barla A
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1466-73. PubMed ID: 21048338
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of Tip-Dissolving Microneedles for Transdermal Drug Delivery of Meloxicam.
Chen J; Huang W; Huang Z; Liu S; Ye Y; Li Q; Huang M
AAPS PharmSciTech; 2018 Apr; 19(3):1141-1151. PubMed ID: 29218581
[TBL] [Abstract][Full Text] [Related]
11. Design, characterization, and modeling of a chitosan microneedle patch for transdermal delivery of meloxicam as a pain management strategy for use in cattle.
Castilla-Casadiego DA; Carlton H; Gonzalez-Nino D; Miranda-Muñoz KA; Daneshpour R; Huitink D; Prinz G; Powell J; Greenlee L; Almodovar J
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111544. PubMed ID: 33255096
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin-based oral dissolving films formulation of taste-masked meloxicam.
Samprasit W; Akkaramongkolporn P; Kaomongkolgit R; Opanasopit P
Pharm Dev Technol; 2018 Jun; 23(5):530-539. PubMed ID: 29103353
[TBL] [Abstract][Full Text] [Related]
13. Influence of ion-pairing and chemical enhancers on the transdermal delivery of meloxicam.
Zhang JY; Fang L; Tan Z; Wu J; He ZG
Drug Dev Ind Pharm; 2009 Jun; 35(6):663-70. PubMed ID: 19259875
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
Aghazadeh-Habashi A; Jamali F
Eur J Pharm Biopharm; 2008 Nov; 70(3):889-94. PubMed ID: 18715548
[TBL] [Abstract][Full Text] [Related]
15. Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes.
Duangjit S; Pamornpathomkul B; Opanasopit P; Rojanarata T; Obata Y; Takayama K; Ngawhirunpat T
Int J Nanomedicine; 2014; 9():2005-17. PubMed ID: 24851047
[TBL] [Abstract][Full Text] [Related]
16. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
Jain SK; Gupta Y; Jain A; Amin S
Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
[TBL] [Abstract][Full Text] [Related]
17. Development of meloxicam in situ implant formulation by quality by design principle.
Ibrahim HM; Ahmed TA; Hussain MD; Rahman Z; Samy AM; Kaseem AA; Nutan MT
Drug Dev Ind Pharm; 2014 Jan; 40(1):66-73. PubMed ID: 23298324
[TBL] [Abstract][Full Text] [Related]
18. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
19. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
Bachhav YG; Patravale VB
Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
[TBL] [Abstract][Full Text] [Related]
20. Dissolving microneedle patch-assisted transdermal delivery of methotrexate improve the therapeutic efficacy of rheumatoid arthritis.
Zhao W; Zheng L; Yang J; Ma Z; Tao X; Wang Q
Drug Deliv; 2023 Dec; 30(1):121-132. PubMed ID: 36533887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
